DK327182A - WRAPPED POLYOXIDES AND PROCEDURES FOR PREPARING THEREOF - Google Patents

WRAPPED POLYOXIDES AND PROCEDURES FOR PREPARING THEREOF Download PDF

Info

Publication number
DK327182A
DK327182A DK327182A DK327182A DK327182A DK 327182 A DK327182 A DK 327182A DK 327182 A DK327182 A DK 327182A DK 327182 A DK327182 A DK 327182A DK 327182 A DK327182 A DK 327182A
Authority
DK
Denmark
Prior art keywords
capsular
polyosides
bacteriae
give
retained material
Prior art date
Application number
DK327182A
Other languages
Danish (da)
Inventor
Demetre Yavordios
Mireille Cousin
Original Assignee
Berri Balzac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berri Balzac filed Critical Berri Balzac
Publication of DK327182A publication Critical patent/DK327182A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0266Klebsiella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) Process for the production of immunogenic capsular polyosides from capsulated bacteriae containing same, characterised in that it consists in cultivating the bacteriae in a synthetic medium which may contain up to about 0.5% by weight of naturally occuring materials ; at the end of the growth stage of said culture removing the microbial bodies, submitting the liquid phase after removal of the microbial bodies to a filtration through a membrane which retains the molecules of a molecular weight of 100 000 daltons or more, to give a capsular polyosides-rich retained material ; and removing the proteins, the nucleic acids and the lipids from said retained material, to give a purified capsular polyoside. 1. Claims (for the Contracting State AT) Process for the production of immunogenic capsular polyosides from capsulated bacteriae containing same, characterised in that it consists in cultivating the bacteriae in a synthetic medium which may contain up to about 0.5% by weight of naturally occuring materials ; at the end of the growth stage of said culture removing the microbial bodies, submitting the liquid phase after removal of the microbial bodies to a filtration through a membrane which retains the molecules of a molecular weight of 100 000 daltons or more, to give a capsular polyosides-rich retained material ; and removing the proteins, the nucleic acids and the lipids from said retained material, to give a purified capsular polyoside.
DK327182A 1981-07-30 1982-07-21 WRAPPED POLYOXIDES AND PROCEDURES FOR PREPARING THEREOF DK327182A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8114842A FR2510606A1 (en) 1981-07-30 1981-07-30 PROCESS FOR OBTAINING CAPSULAR POLYOSIDES, CAPSULAR POLYOSIDES THUS OBTAINED AND THEIR APPLICATION TO THE PREPARATION OF VACCINES

Publications (1)

Publication Number Publication Date
DK327182A true DK327182A (en) 1983-01-31

Family

ID=9261011

Family Applications (1)

Application Number Title Priority Date Filing Date
DK327182A DK327182A (en) 1981-07-30 1982-07-21 WRAPPED POLYOXIDES AND PROCEDURES FOR PREPARING THEREOF

Country Status (11)

Country Link
EP (1) EP0071515B1 (en)
AT (1) ATE16244T1 (en)
CA (1) CA1206905A (en)
DD (1) DD202623A5 (en)
DE (1) DE3267160D1 (en)
DK (1) DK327182A (en)
ES (1) ES8305827A1 (en)
FR (1) FR2510606A1 (en)
IE (1) IE53582B1 (en)
NO (1) NO159394C (en)
PT (1) PT75301B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683844D1 (en) * 1986-03-27 1992-03-19 Schweiz Serum & Impfinst VACCINE OF KLEBSIELLA CAPSULPOLYSACCHARID.
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
KR100914702B1 (en) * 2000-03-16 2009-08-28 더 칠드런스 호스피탈 오브 필라델피아 Modulating production of pneumococcal capsular polysaccharide
NZ511680A (en) 2001-05-14 2004-07-30 Univ Waikato Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases
GB0522303D0 (en) * 2005-11-01 2005-12-07 Chiron Srl Culture method
US8398985B2 (en) 2007-04-23 2013-03-19 Serum Institute Of India Ltd. Antigenic polysaccharides and process for their preparation
WO2011148382A1 (en) 2010-05-28 2011-12-01 Biological E Limited An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol.
WO2011151841A1 (en) * 2010-05-31 2011-12-08 Panacea Biotec Limited Fermentation process for streptococcus pneumoniae
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
EP3562503A2 (en) 2016-12-30 2019-11-06 Sutrovax, Inc. Polypeptide-antigen conjugates with non-natural amino acids
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
WO2024062494A1 (en) 2022-09-19 2024-03-28 Biological E Limited Method for the purification of capsular polysaccharides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166963A (en) * 1936-11-19 1939-07-25 Sharp & Dohme Inc Antigenic polysaccharide complex
US2528972A (en) * 1947-05-15 1950-11-07 Western Reserve University Prophylactic toxoid compound and method of making same
FR2407262A1 (en) * 1977-10-27 1979-05-25 Cassenne Lab Sa NEW POLYSACCHARIDES MICROBIAL BODY EXTRACTS OF HAEMOPHILUS INFLUENZAE, PROCESS FOR THE PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS OF THESE NEW PRODUCTS
CA1115210A (en) * 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
US4287173A (en) * 1979-09-24 1981-09-01 Merck & Co., Inc. Vaccine for dental caries
US4307080A (en) * 1979-09-24 1981-12-22 Merck & Co., Inc. Meningitis vaccine

Also Published As

Publication number Publication date
NO822592L (en) 1983-01-31
DE3267160D1 (en) 1985-12-05
IE821705L (en) 1983-01-30
EP0071515B1 (en) 1985-10-30
ES514496A0 (en) 1983-04-16
ATE16244T1 (en) 1985-11-15
DD202623A5 (en) 1983-09-28
ES8305827A1 (en) 1983-04-16
EP0071515A1 (en) 1983-02-09
PT75301B (en) 1984-07-31
NO159394C (en) 1988-12-21
FR2510606B1 (en) 1984-10-26
NO159394B (en) 1988-09-12
IE53582B1 (en) 1988-12-21
CA1206905A (en) 1986-07-02
FR2510606A1 (en) 1983-02-04
PT75301A (en) 1982-08-01

Similar Documents

Publication Publication Date Title
DK327182A (en) WRAPPED POLYOXIDES AND PROCEDURES FOR PREPARING THEREOF
IL84699A (en) Process for transforming plant protoplasts
ATE91155T1 (en) PROCESS FOR PREPARING NUCLEIC ACID FOR HYBRIDIZATION.
DE69112463D1 (en) Device for the production of monocrystals according to the Czochralski process.
ES8505818A1 (en) Method for the production of HA fraction containing protective antigens of Bordetella pertussis and pertussis vaccine.
ES8600401A1 (en) New furanone derivatives, process for the preparation thereof and use thereof.
DE69109886D1 (en) Process for the preparation of human factor VIII and its analogs.
DK232483A (en) PROCEDURE FOR MANUFACTURING WS 6049 CONNECTIONS
FR2545099B1 (en) NOVEL STRAIN OF TRICHODERMA HARZIANUM METHOD FOR ISOLATING THIS STRAIN, METHOD FOR CULTURING THIS STRAIN, NEW PEPTIDES PRODUCED BY THIS STRAIN, AND APPLICATION OF THIS STRAIN AND THESE NEW PEPTIDES OR THE PRODUCT OBTAINED BY THE CULTURE PROCESS AS A MEANS OF BIOLOGY IN THE FORM OF A PHYTOSANITARY PRODUCT
DE3860798D1 (en) POROESES PRODUCT FOR PLANT CULTURE AND METHOD FOR THE PRODUCTION THEREOF.
DE3584610D1 (en) LIVING MICRO-ORGANISMS CONTAINING LIQUID PREPARATION, METHOD FOR THE PRODUCTION THEREOF, LIVING MICRO-ORGANISMS CONTAINING PELLETED PRODUCT AND METHOD FOR THE PRODUCTION THEREOF.
DE69325449D1 (en) METHOD FOR DEVELOPING NEW PLANT TYPES WITH CAPACITY FOR BONDING NITROGEN ALSO IN THE LEAVES
DE3065316D1 (en) Process for the production of creatinine iminohydrolase by growing micro-organism and nutrient medium for the practice of said process
ATE9100T1 (en) TRICHOSPORON KASHIWAYAMA IFO 1964, CULTURE BROTH, CELL-FREE STERILE LIQUID, STERILE FILTRATE, STERILE SUPERNATANT, STERILE CONCENTRATE AND STERILE DRY PRODUCT OF CULTURE BROTH, PROCESS FOR PREPARATION OF CULTURE BROTH, PHARMACEUTICAL COMPOSITION, COSMETIC TO COMPOSITION.
ATE1235T1 (en) NEW M-ANILIDURETHANES, HERBICIDES CONTAINING THEM AND PROCESSES FOR THEIR PRODUCTION, AND METHODS FOR CONTROLLING UNDESIRABLE PLANT GROWTH.
FR2641938B3 (en) PLATE-LIKE GROUNDLESS GROWING MEDIUM FOR GROWING PLANTS
ATE21033T1 (en) PROCESS FOR THE PRODUCTION OF AN IMMUNOGEN FROM PASTEURELLA MULTOCIDA.
FR2338256A1 (en) NEW ARYLOXY (THIO) CARBONYLAMINOMETHYL ESTERS OF PHENOXYCARBOXYLIC ACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS PLANT GROWTH SUBSTANCES
DE3677217D1 (en) METHOD FOR REGENERATING CORN.
JPS5675095A (en) Preparation of heat-resistant acetic acid kinase
EP0337625A3 (en) Probes
RU93028311A (en) METHOD FOR PRODUCING BIOLOGICALLY ACTIVE SUBSTANCES FROM BIOMASS OF CULTIVATED PLANT CELLS
RU94025893A (en) Method of isolation of biologically active substances
JPS5682095A (en) Purification of fatty acid produced through fermentation process
FR2655659B1 (en) PROCESS FOR INHIBITING THE GROWTH OF MICROORGANISMS IN A CULTURE MEDIUM BEFORE ITS USE, THE MEDIUM THUS OBTAINED AND ITS APPLICATION TO THE CULTURE OF BIFIDOBACTERIA.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment